Sanofi Acquires Emeryville's Dynavax Technologies for $2.2 Billion, Bolstering Vaccine Portfolio Amid Industry Optimism
This story raises questions about governance, accountability, and American values.
Source: Hoodline
1 min read
Sanofi plans to acquire Dynavax Technologies for $2.2 billion, offering a 39% premium on the latter's shares, which may stimulate further biotech deals in the Bay Area.
Original source:
Read at HoodlineHow We See It
New Republican Times Editorial Board